Description
Adamax 5 mg — Opti-Gen Peptides
For laboratory research use only.
Not for human use. Not for veterinary use.
Not licensed by the MHRA. Not a medicinal product.
Research-grade synthetic peptide supplied as a 5 mg sealed vial for lawful laboratory research in the UK. Not a food, supplement or medical device on this page. Not for diagnostic or therapeutic use. Must not be administered to people or animals.
Identification
| Product name | Adamax |
| Also listed as | Adamantane-modified Semax analogue |
| Supplier | Opti-Gen Peptides |
| Contents | 5 mg per vial |
| Parent research peptide | Semax (Met-Glu-His-Phe-Pro-Gly-Pro; CAS 80714-61-0) |
| Class | Synthetic modified heptapeptide analogue |
| Intended use | Laboratory / in-vitro research only |
Confirm the exact sequence on the lot COA. Not Semax.
Quality / storage
Only the lot COA applies. Store as a laboratory chemical under institutional SOP. No preparation, nasal or injection instructions on this page.
Published research context (not product claims)
Semax is an ACTH(4–7) analogue with a Pro-Gly-Pro C-terminus. It has a published set of melanocortin-related and CNS-model papers, and authorised medicinal use in some countries. Those authorisations do not apply to Adamax or to this vial.
Adamax is a catalogue name for an adamantane-modified Semax analogue. Research notes discuss the adamantane group as a way to alter lipophilicity and peptide stability versus Semax in laboratory systems. That is chemistry context, not a benefit claim.
Independent peer-reviewed human evidence specific to Adamax is limited. Semax papers must not be copied across as Adamax product claims.
There is no UK marketing authorisation for Adamax. Nootropic or nasal-spray marketing is not a claim for this listing.
UK notice
18+. Buyer confirms lawful laboratory research use only and will not use or resell for unauthorised human or animal use.
Reviews
There are no reviews yet.